These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6141484)

  • 1. Kappa binding sites in guinea-pig brain membranes: evidence for a dynorphin-resistant subtype.
    Morre M; Bachy A; Gout B; Boigegrain R; Arnone M; Roncucci R
    Life Sci; 1983; 33 Suppl 1():179-82. PubMed ID: 6141484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
    Chavkin C; James IF; Goldstein A
    Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes.
    Tam SW
    Eur J Pharmacol; 1985 Feb; 109(1):33-41. PubMed ID: 2986989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution in the receptor binding of putative mu and kappa opiates.
    Medzihradsky F; Dahlstrom PJ; Woods JH; Fischel SV; Mitsos SE
    Life Sci; 1984 May; 34(22):2129-38. PubMed ID: 6145076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
    Nock B; Rajpara A; O'Connor LH; Cicero TJ
    Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous ligands for sigma opioid receptors in the brain ("sigmaphin"): evidence from binding assays.
    Su TP; Weissman AD; Yeh SY
    Life Sci; 1986 Jun; 38(24):2199-210. PubMed ID: 3012236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of two different buffers on the high affinity 3H-ethylketocyclazocine and 3H-SKF10047 binding to guinea pig brain membranes.
    Grynne BH; Maurset AR; Holmen AT; Enger M
    Acta Pharmacol Toxicol (Copenh); 1984 Mar; 54(3):195-200. PubMed ID: 6144235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.
    Clark JA; Liu L; Price M; Hersh B; Edelson M; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):461-8. PubMed ID: 2553920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of the binding of [3H]bremazocine in guinea-pig brain: evidence for multiplicity of the kappa-opioid receptors.
    Tiberi M; Magnan J
    Can J Physiol Pharmacol; 1989 Oct; 67(10):1336-44. PubMed ID: 2558788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature dependence of the binding of mu, delta and kappa agonists to the opiate receptors in guinea-pig brain.
    Borea PA; Bertelli GM; Gilli G
    Eur J Pharmacol; 1988 Feb; 146(2-3):247-52. PubMed ID: 2836208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human placental opioid receptors by 3H-ethylketocyclazocine and 3H-naloxone binding.
    Agbas A; Simon J; Avni Oktem H; Varga E; Borsodi A
    Neuropeptides; 1988 Oct; 12(3):171-6. PubMed ID: 2907370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of opioid binding sites in murine neuroblastoma.
    Zagon IS; Goodman SR; McLaughlin PJ
    Brain Res; 1988 May; 449(1-2):80-8. PubMed ID: 2899449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of opioid receptors in guinea-pig cerebellum and human placenta.
    Ishizuka Y; Oka T; Kenjo T; Fujii A
    Tokai J Exp Clin Med; 1986 Aug; 11(3):179-84. PubMed ID: 3039693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites.
    Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
    J Neurochem; 1985 Sep; 45(3):688-99. PubMed ID: 2993510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding characteristics of kappa opioids in rat brain. A comparison of in vitro binding paradigms.
    Weyhenmeyer JA; Mack KJ
    Neuropharmacology; 1985 Feb; 24(2):111-5. PubMed ID: 2986030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
    Werling LL; Brown SR; Puttfarcken P; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL; Zarr GD; Brown SR; Cox BM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.